H5 bird flu reaches Australia: what the virus is, where it came from and what the human risk really is

Australia's mainland silence on bird flu ended this past weekend. Federal agriculture minister Julie Collins confirmed that a migratory brown skua found sick in Western Australia had died of the H5N1 virus. It is the first confirmed case of the deadly H5 strain on Australia's mainland — a continent whose biogeographical isolation had until now kept it out of reach.

What is H5? H5 is one subtype of the haemagglutinin (H) surface protein on influenza A viruses; N1 is one of the neuraminidase (N) subtypes. The H5N1 strain was first identified in China in 1996 and has since caused devastating losses among bird and mammal populations across Asia, Africa, Europe and the Americas. Australia had been the last major continent it had not reached.

The virus is carried mainly by migratory waterfowl — ducks, geese and seabirds act as the reservoir. The brown skua, which migrates between polar regions, may have carried the virus from Antarctic colonies into Australia. The first H5N1 deaths in Antarctica were reported during the 2024-25 season; scientists had been forecasting Australia's eventual exposure ever since.

Why a "genuine wildlife emergency"? Because H5N1 has driven the deaths of tens of millions of wild birds across Europe and the Americas. Recovery of decimated colony-nesting seabird populations — which do not breed at industrial scale and cannot be repopulated by farming — can take decades. Australia's endemic waterbirds — pelicans, black swans, plovers — have no previous exposure and no inherited immunity.

The risk to livestock is serious. Since March 2024, H5N1 has been circulating in US dairy cattle — a host jump the virus's family tree had not previously predicted. Australia's poultry sector has scrambled to lift biosecurity protocols: tightened entry and exit controls at sheds, netting to keep wild birds out, mandatory reporting of dead birds within 24 hours.

Human risk is currently low but not zero. Globally H5N1 has caused about 900 confirmed human cases since 2003, with a case-fatality rate around 50 per cent — though cases have skewed heavily toward poultry workers with intense animal exposure and toward patients in lower-income countries with limited health infrastructure. Sustained person-to-person spread has not yet occurred anywhere.

For the virus to acquire humans as a sustained host, it has to change its receptor-binding profile. Today H5N1 preferentially binds α-2,3-linked sialic acid receptors in the lower respiratory tract — receptors that are sparser and deeper in humans than in birds. If mutations allowed binding to α-2,6-linked receptors in the upper airway, the capacity for human-to-human transmission would rise substantially.

Public-health advice is clear. Sick or dead wild birds should not be handled; sightings should be reported to local animal-health authorities. Eggs and dairy from Australian farms are safe under standard heat-treatment processing; pasteurised milk and well-cooked eggs eliminate the risk. Raw milk is the principal vehicle for the recent human cases in the US.

For clinicians: patients with relevant animal-contact history and flu-like illness should be tested with H5N1-specific PCR. Oseltamivir — Tamiflu — remains the antiviral to which the virus is currently susceptible; benefit depends on initiating treatment within the first 48 hours. Australian public-health labs have opened a surveillance line for clinicians dealing with animal-exposure cases.

Long-term questions are still open. Vaccine development is under way: Sanofi, GSK and Australia's CSL are refreshing H5N1-targeted vaccine stockpiles. Wildlife surveillance networks are being expanded — Australia's CSIRO has launched coastal sampling of skuas, murres and other seabirds. "Australia's geographical isolation advantage is over; its preparedness advantage is yet to begin," said the CSIRO's chief animal-health scientist Frank Wong.